Adults with acute lymphoblastic leukemia and translocation (1;19) abnormality have a favorable outcome with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with methotrexate and high-dose cytarabine chemotherapy.

Garg, Ravin

Adults with acute lymphoblastic leukemia and translocation (1;19) abnormality have a favorable outcome with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with methotrexate and high-dose cytarabine chemotherapy. [electronic resource] - Cancer May 2009 - 2147-54 p. digital

Publication Type: Journal Article

0008-543X

10.1002/cncr.24266 doi


Adolescent
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Chromosomes, Human, Pair 1
Chromosomes, Human, Pair 19
Cyclophosphamide--therapeutic use
Cytarabine--administration & dosage
Dexamethasone--therapeutic use
Doxorubicin--therapeutic use
Humans
Methotrexate--administration & dosage
Middle Aged
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma--drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy
Translocation, Genetic
Treatment Outcome
Vincristine--therapeutic use